Posts

Cellenkos Announces US FDA Orphan Drug Designation Granted to CK0801 (Allogeneic Cord Blood derived T regulatory Cell Product) for Treatment of Aplastic Anemia

Cellenkos Announces US FDA Orphan Drug Designation Gran...

May 12, 2025 0

HOUSTON, April 14, 2025 /PRNewswire/ -- Cellenkos Inc., a clinical-stage biotech...

Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

Verve Therapeutics Receives U.S. FDA Fast Track Designa...

May 12, 2025 0

BOSTON, April 11, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage ...

FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

FDA Announces Plan to Phase Out Animal Testing Requirem...

May 12, 2025 0

April 10, 2025 -- Today, the U.S. Food and Drug Administration is taking a groun...

Tolebrutinib Phase 3 Data Published in NEJM Demonstrate Benefit on Disability Progression in Multiple Sclerosis

Tolebrutinib Phase 3 Data Published in NEJM Demonstrate...

May 12, 2025 0

Paris, April 8, 2025. The New England Journal of Medicine (NEJM) published posit...

Pfizer Discontinues Development of Oral GLP-1 Receptor Agonist Danuglipron

Pfizer Discontinues Development of Oral GLP-1 Receptor ...

May 12, 2025 0

NEW YORK--(BUSINESS WIRE) April 14, 2025 -- Pfizer Inc. (NYSE: PFE) today announ...

Novo Nordisk Warns Consumers About Counterfeit Ozempic (semaglutide) Injection 1 mg in the US

Novo Nordisk Warns Consumers About Counterfeit Ozempic ...

May 12, 2025 0

PLAINSBORO, N.J., April 14, 2025 /PRNewswire/ -- Novo Nordisk has become aware o...

Click Therapeutics Announces FDA Marketing Authorization for CT-132, the First Prescription Digital Therapeutic for the Preventive Treatment of Episodic Migraine in the United States

Click Therapeutics Announces FDA Marketing Authorizatio...

May 12, 2025 0

NEW YORK, N.Y. (April 15, 2025) – Click Therapeutics, Inc., (“Click”) a leader i...

Bristol Myers Squibb Provides Update on Camzyos Phase 3 ODYSSEY-HCM Trial

Bristol Myers Squibb Provides Update on Camzyos Phase 3...

May 12, 2025 0

PRINCETON, N.J.-- April 14, 2025 (BUSINESS WIRE) -- Bristol Myers Squibb (NYSE:...

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide

Ironwood Pharmaceuticals Provides Clinical and Regulato...

May 12, 2025 0

BOSTON--(BUSINESS WIRE) April 14, 2025 -- Ironwood Pharmaceuticals, Inc. (Nasda...

BlueRock Therapeutics Announces Publication in Nature of 18-Month Data from Phase 1 Clinical Trial for Bemdaneprocel, an Investigational Cell Therapy for Parkinson’s Disease

BlueRock Therapeutics Announces Publication in Nature o...

May 12, 2025 0

Cambridge MA, USA, April 16, 2025 – BlueRock Therapeutics LP, a clinical-stage c...

Repurposing Blood Pressure Drug Reserpine May Prevent Vision Loss in Inherited Blinding Diseases

Repurposing Blood Pressure Drug Reserpine May Prevent V...

May 12, 2025 0

Tuesday, April 15, 2025 -- New studies in rats suggest the drug reserpine, appro...

Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B

Precision BioSciences Receives U.S. FDA Fast Track Desi...

May 12, 2025 0

DURHAM, N.C.--(BUSINESS WIRE)--Apr. 15, 2025-- Precision BioSciences, Inc. (Nasd...

NIH Study Reveals How Inflammation Makes Touch Painful

NIH Study Reveals How Inflammation Makes Touch Painful

May 12, 2025 0

April 23, 2025 -- Researchers at the National Institutes of Health (NIH) have di...

Bristol Myers Squibb Announces Topline Results from Phase 3 ARISE Trial Evaluating Cobenfy (xanomeline and trospium chloride) as an Adjunctive Treatment to Atypical Antipsychotics in Adults with Schizophrenia

Bristol Myers Squibb Announces Topline Results from Pha...

May 12, 2025 0

PRINCETON, N.J.--(BUSINESS WIRE) Apr 22, 2025 -- Bristol Myers Squibb (NYSE: BM...

Orforglipron Demonstrated Statistically Significant Eff...

May 12, 2025 0

INDIANAPOLIS, April 17, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) t...

The gut health benefits of sauerkraut

May 12, 2025 0

Is sauerkraut more than just a tangy topping? A new University of California, Da...

Potential treatment for Parkinson's using investig...

May 12, 2025 0

A stem cell-based therapy initially developed at Memorial Sloan Kettering Cancer...

Researchers develop an LSD analogue with potential for ...

May 12, 2025 0

University of California, Davis researchers have developed a new, neuroplasticit...

Scientists achieve record-breaking growth in miniature,...

May 12, 2025 0

While organoids aim to mimic human organs, the liver's repertoire of complex fun...

Popular diabetes medications, including GLP-1 drugs, ma...

May 12, 2025 0

A study led by researchers in the University of Florida College of Pharmacy has ...

Existing drug has potential for immune paralysis

May 12, 2025 0

When the immune system does not function properly, individuals become more susce...

Study finds pinworm medication has potential to treat a...

May 12, 2025 0

A common pinworm medication may stop and reverse cancer growth in Merkel cell ca...

Empowering antibodies to better activate the immune system

May 12, 2025 0

Antibodies are best known for their ability to latch onto and neutralize bacteri...

BlueRock Therapeutics announces publication in Nature o...

May 12, 2025 0

BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.